New Report Just Published Neurostimulation - A Global Market Perspective
© Reportlinker PRWire 2009 - By Robert Miller
17.11.2009 19:35:03
(live-PR.com) - Reportlinker.com announces that a new market research report related to the Medical Equipment and Supply industry is available in its catalogue.
More information regarding this report:Neurostimulation - A Global Market Perspective
http://www.reportlinker.com/p0164232/Neurostimulation-A-Global-Market-Perspective.html#utm_source=LivePR&utm_medium=pr&utm_campaign=LivePR
The world
neurostimulation market stands enthused by the growing base of aging population, and the resultant rise in age-related diseases such as, Parkinson's, and Alzheimer's disease. Widespread prevalence of neurological disorders and conditions, and the associated costs to society in terms of declining productivity, and reduced quality of life, offer a business case for the neurostimulation treatment modality.
Demand for a higher quality of life, rising awareness among both physicians and patients, and improved patient outcomes are together, helping drive growth in the market. Influx of new players is giving rise to increased investments and research and developments. This is expected to lead to a spurt in technology innovations, and development of novel, advanced products, such as closed-loop system neurostimulators, which are designed to continuously stimulate the nervous system.
Innovations in the field of brain imaging, interactive computer guidance devices, and single cell microelectrode recordings, are all helping drive the effectiveness, and hence growth of neurostimulation. With public and private health insurance companies mulling reimbursements for neurostimulation procedures and devices, the market stands to gain attractively in the medium to long run.
These and other market data and trends are presented in "Neurostimulation: A Global Market Perspective" by BizAcumen LLC. Our reports are designed to be most comprehensive in geographic coverage and vertical market analyses.
NEUROSTIMULATION BMR-1032
CONTENTS
1. METHODOLOGY 1
Study Reliability and Reporting Limitations 1
Disclaimers 2
Quantitative Techniques and Reporting Level 3
2. GLOBAL MARKET OVERVIEW AND OUTLOOK 3
Current Scenario 4
Neurostimulation Therapy Gets Popular 4
Technological Advancements So Far 5
SCS - The New Painkiller 5
Future Prospects 6
Obesity Control to Spur Market Growth in Future 6
3. COMPETITIVE SCENARIO 7
Worldwide Neurostimulation Market: Leading Players by Product
Segment 8
Product Offerings of Leading Players in the Neurostimulation
Market 9
Select Spinal Cord Stimulation Product Offerings of St. Jude
and Medtronic 9
Stimulation Parameters of Select SCS Products 10
Companies Researching Neurostimulator Applications by Indication 10
4. TRENDS AND ISSUES 11
Chip Makers Struggle to Meet Quality Demand 11
Market Growth Attracts New Investors 11
Neurostimulation on a Rise with Growing Indications 11
Neurostimulation Market Marked by High Entry Barriers 11
Increasing Acceptance of Neurostimulation due to Advanced
Clinical Benefits 12
Powering Neurostimulation Devices- The Key to Success 12
Market Development Initiatives to Fuel Market Growth 13
Exploring Market Opportunities - The Technology Way 13
Neurostimulation Devices - Growing Awareness and Acceptance
Among Physicians 14
Synergy with Pharma and Biotech Companies reates New Avenues 14
Third-Party Reimbursement - A Vital Role to Play 15
5. PRODUCT FACTS 15
Spinal Cord Stimulation (SCS) 15
Radio Frequency (RF) Systems 16
Implantable Pulse Generator Systems (IPGs) 16
Deep Brain Stimulation (DBS) 16
Sacral Nerve Stimulation (SNS) 16
Vagus Nerve Stimulation (VNS) 16
6. CORPORATE DEVELOPMENTS 17
Cyberkinetics and Neurometrix Form Joint Venture to Develop
Andara(TM) OFS(TM) 17
Medtronic Receives FDA Approval to Market RestoreULTRA(TM) 18
St. Jude Bags CE Mark and FDA Approvals for Eon Mini(TM) 18
St. Jude Medical Initiates Clinical Study of DBS 18
ANS Bags CE Mark Approval for Rapid Programmer 3.0 18
Northstar Completes Trial of Renova-ST(TM) 19
Medtronic Delivers Procedural Intelligence in StealthStation(R)
System 19
Medtronic Unveils Patient Referral Advisor Software in US 19
Greatbatch Acquires Enpath Medical 19
Greatbatch to Acquire Quan Emerteq 20
Critical Therapeutics Grants Global License to Innovative
Metabolics 20
Biomet Merges with LVB Acquisition 21
US Patent and Trademark Office Issues Cyberkinetics' Patent
for Andara(TM)OFS(TM) Therapy 21
Cyberonics Licenses Obesity-Related Patents 21
Stryker Invests in Afferent Corp 21
Medtronic Receives PMA Approval for Specify(TM) 5-6-5 Surgical Lead 22
BioControl Initiates CardioFit(TM) System's Trials 22
Medtronic Initiates Post-Market Study of InterStim(TM) 22
Cyberkinetics Successfully Tests Andara(TM)OFS(TM) System 22
Medtronic Completes Implants in SANTE Trial of Deep Brain
Stimulation 22
Cyberonics Receives US FDA Approval for Demipulse(TM) and
Demipulse Duo(TM) 23
Cyberonics Signs Licensing Agreement with Ethicon Endo-Surgery 23
Boston Scientific Introduces Smallest Rechargeable SCS System 23
Tennessee Inventors Develops Apparatus of Deep Brain Stimulator 23
California Inventors Develop IPG 24
7. MAJOR PLAYERS 24
Boston Scientific Corp. (USA) 24
Cyberonics, Inc. (USA) 24
Medtronic, Inc. (USA) 24
St. Jude Medical, Inc. (USA) 25
8. MARKET ANALYTICS 25
9. THE UNITED STATES 32
Industry Overview 32
Potential Growth for Neurostimulation Systems in the US 33
Migraine Devices - New Frontiers for Neurostimulation 33
Competition 34
10. REST OF WORLD 38
EXHIBITS
Table 1: Percentage Breakdown of Leading Players in the
Neurostimulation Market - 2008
Table 2: Percentage Breakdown of Neurostimulation Market by
Disorder: 2008-2010
Table 3: Global Neurostimulation Market by Region for the
Period 2007-2012 (Sales in US$ Million)
Table 4: Percentage Breakdown of Global Neurostimulation
Market by Region for the Years 2008 and 2012
Table 5: Global Spinal Cord Stimulators (SCS) Market by Region
for the Period 2007-2012 (Sales in US$ Million)
Table 6: Percentage Breakdown of Global Spinal Cord
Stimulators (SCS) Market by Region for the Years 2008 and 2012
Table 7: Global Spinal Cord Stimulators (SCS) Market by
Segment for the Period 2007-2012 (Sales in US$ Million)
Table 8: Percentage Breakdown of Global Spinal Cord
Stimulators (SCS) Market by Segment for the Years 2008 and 2012
Table 9: Global Radio Frequency (RF) Systems Market by Region
for the Period 2007-2012 (Sales in US$ Million)
Table 10: Percentage Breakdown of Global Radio Frequency (RF)
Systems Market by Region for the Years 2008 and 2012
Table 11: Global Implantable Pulse Generator (IPG) Market by
Region for the Period 2007-2012 (Sales in US$ Million)
Table 12: Percentage Breakdown of Global Implantable Pulse
Generator (IPG) Market by Region for the Years 2008 and 2012
Table 13: Global Deep Brain Stimulators (DBS) Market by Region
for the Period 2007-2012 (Sales in US$ Million)
Table 14: Percentage Breakdown of Global Deep Brain
Stimulators (DBS) Market by Region for the Years 2008 and 2012
Table 15: Global Sacral Nerve Stimulators (SNS) Market by
Region for the Period 2007-2012 (Sales in US$ Million)
Table 16: Percentage Breakdown of Global Sacral Nerve
Stimulators (SNS) Market by Region for the Years 2008 and 2012
Table 17: Global Vagus Nerve Stimulators (VNS) Market by
Region for the Period 2007-2012 (Sales in US$ Million)
Table 18: Percentage Breakdown of Global Vagus Nerve
Stimulators (VNS) Market by Region for the Years 2008 and 2012
Table 19: Percentage Breakdown of Leading Players in the US
Neurostimulation Market - 2008
Table 20: Neurostimulation Market by Segment in the US:
2007-2012 (Sales in Units)
Table 21: Percentage Breakdown (Unit Sales) of
Neurostimulation Market by Segment in the US for the Years
2008 and 2012
Table 22: Neurostimulation Market by Segment in the US:
2007-2012 (Sales in US$ Million)
Table 23: Percentage Breakdown (Value Sales) of
Neurostimulation Market by Segment in the US for the Years
2008 and 2012
Table 24: Spinal Cord Stimulators Market by Segment in the US:
2007-2012 (Sales in Units)
Table 25: Percentage Breakdown (Unit Sales) of Spinal Cord
Stimulators Market by Segment in the US for the Years 2008 and
2012
Table 26: Spinal Cord Stimulators Market by Segment in the
US: 2007-2012 (Sales in US$ Million)
Table 27: Percentage Breakdown (Value Sales) of Spinal Cord
Stimulators Market by Segment in the US for the Years 2008 and
2012
Table 28: Neurostimulation Market by Segment in the Rest of
World: 2007-2012 (Sales in US$ Million)
Table 29: Percentage Breakdown of Neurostimulation Market by
Segment in the Rest of World for the Years 2008 and 2012
Table 30: Spinal Cord Stimulators Market by Segment in the
Rest of World: 2007-2012 (Sales in US$ Million)
Table 31: Percentage Breakdown of Spinal Cord Stimulators
Market by Segment in the Rest of World for the Years 2008 and
2012
COMPANIES PROFILED
More information regarding this report:Neurostimulation - A Global Market Perspective
http://www.reportlinker.com/p0164232/Neurostimulation-A-Global-Market-Perspective.html#utm_source=LivePR&utm_medium=pr&utm_campaign=LivePR
The world
|
|
Demand for a higher quality of life, rising awareness among both physicians and patients, and improved patient outcomes are together, helping drive growth in the market. Influx of new players is giving rise to increased investments and research and developments. This is expected to lead to a spurt in technology innovations, and development of novel, advanced products, such as closed-loop system neurostimulators, which are designed to continuously stimulate the nervous system.
Innovations in the field of brain imaging, interactive computer guidance devices, and single cell microelectrode recordings, are all helping drive the effectiveness, and hence growth of neurostimulation. With public and private health insurance companies mulling reimbursements for neurostimulation procedures and devices, the market stands to gain attractively in the medium to long run.
These and other market data and trends are presented in "Neurostimulation: A Global Market Perspective" by BizAcumen LLC. Our reports are designed to be most comprehensive in geographic coverage and vertical market analyses.
NEUROSTIMULATION BMR-1032
CONTENTS
1. METHODOLOGY 1
Study Reliability and Reporting Limitations 1
Disclaimers 2
Quantitative Techniques and Reporting Level 3
2. GLOBAL MARKET OVERVIEW AND OUTLOOK 3
Current Scenario 4
Neurostimulation Therapy Gets Popular 4
Technological Advancements So Far 5
SCS - The New Painkiller 5
Future Prospects 6
Obesity Control to Spur Market Growth in Future 6
3. COMPETITIVE SCENARIO 7
Worldwide Neurostimulation Market: Leading Players by Product
Segment 8
Product Offerings of Leading Players in the Neurostimulation
Market 9
Select Spinal Cord Stimulation Product Offerings of St. Jude
and Medtronic 9
Stimulation Parameters of Select SCS Products 10
Companies Researching Neurostimulator Applications by Indication 10
4. TRENDS AND ISSUES 11
Chip Makers Struggle to Meet Quality Demand 11
Market Growth Attracts New Investors 11
Neurostimulation on a Rise with Growing Indications 11
Neurostimulation Market Marked by High Entry Barriers 11
Increasing Acceptance of Neurostimulation due to Advanced
Clinical Benefits 12
Powering Neurostimulation Devices- The Key to Success 12
Market Development Initiatives to Fuel Market Growth 13
Exploring Market Opportunities - The Technology Way 13
Neurostimulation Devices - Growing Awareness and Acceptance
Among Physicians 14
Synergy with Pharma and Biotech Companies reates New Avenues 14
Third-Party Reimbursement - A Vital Role to Play 15
5. PRODUCT FACTS 15
Spinal Cord Stimulation (SCS) 15
Radio Frequency (RF) Systems 16
Implantable Pulse Generator Systems (IPGs) 16
Deep Brain Stimulation (DBS) 16
Sacral Nerve Stimulation (SNS) 16
Vagus Nerve Stimulation (VNS) 16
6. CORPORATE DEVELOPMENTS 17
Cyberkinetics and Neurometrix Form Joint Venture to Develop
Andara(TM) OFS(TM) 17
Medtronic Receives FDA Approval to Market RestoreULTRA(TM) 18
St. Jude Bags CE Mark and FDA Approvals for Eon Mini(TM) 18
St. Jude Medical Initiates Clinical Study of DBS 18
ANS Bags CE Mark Approval for Rapid Programmer 3.0 18
Northstar Completes Trial of Renova-ST(TM) 19
Medtronic Delivers Procedural Intelligence in StealthStation(R)
System 19
Medtronic Unveils Patient Referral Advisor Software in US 19
Greatbatch Acquires Enpath Medical 19
Greatbatch to Acquire Quan Emerteq 20
Critical Therapeutics Grants Global License to Innovative
Metabolics 20
Biomet Merges with LVB Acquisition 21
US Patent and Trademark Office Issues Cyberkinetics' Patent
for Andara(TM)OFS(TM) Therapy 21
Cyberonics Licenses Obesity-Related Patents 21
Stryker Invests in Afferent Corp 21
Medtronic Receives PMA Approval for Specify(TM) 5-6-5 Surgical Lead 22
BioControl Initiates CardioFit(TM) System's Trials 22
Medtronic Initiates Post-Market Study of InterStim(TM) 22
Cyberkinetics Successfully Tests Andara(TM)OFS(TM) System 22
Medtronic Completes Implants in SANTE Trial of Deep Brain
Stimulation 22
Cyberonics Receives US FDA Approval for Demipulse(TM) and
Demipulse Duo(TM) 23
Cyberonics Signs Licensing Agreement with Ethicon Endo-Surgery 23
Boston Scientific Introduces Smallest Rechargeable SCS System 23
Tennessee Inventors Develops Apparatus of Deep Brain Stimulator 23
California Inventors Develop IPG 24
7. MAJOR PLAYERS 24
Boston Scientific Corp. (USA) 24
Cyberonics, Inc. (USA) 24
Medtronic, Inc. (USA) 24
St. Jude Medical, Inc. (USA) 25
8. MARKET ANALYTICS 25
9. THE UNITED STATES 32
Industry Overview 32
Potential Growth for Neurostimulation Systems in the US 33
Migraine Devices - New Frontiers for Neurostimulation 33
Competition 34
10. REST OF WORLD 38
EXHIBITS
Table 1: Percentage Breakdown of Leading Players in the
Neurostimulation Market - 2008
Table 2: Percentage Breakdown of Neurostimulation Market by
Disorder: 2008-2010
Table 3: Global Neurostimulation Market by Region for the
Period 2007-2012 (Sales in US$ Million)
Table 4: Percentage Breakdown of Global Neurostimulation
Market by Region for the Years 2008 and 2012
Table 5: Global Spinal Cord Stimulators (SCS) Market by Region
for the Period 2007-2012 (Sales in US$ Million)
Table 6: Percentage Breakdown of Global Spinal Cord
Stimulators (SCS) Market by Region for the Years 2008 and 2012
Table 7: Global Spinal Cord Stimulators (SCS) Market by
Segment for the Period 2007-2012 (Sales in US$ Million)
Table 8: Percentage Breakdown of Global Spinal Cord
Stimulators (SCS) Market by Segment for the Years 2008 and 2012
Table 9: Global Radio Frequency (RF) Systems Market by Region
for the Period 2007-2012 (Sales in US$ Million)
Table 10: Percentage Breakdown of Global Radio Frequency (RF)
Systems Market by Region for the Years 2008 and 2012
Table 11: Global Implantable Pulse Generator (IPG) Market by
Region for the Period 2007-2012 (Sales in US$ Million)
Table 12: Percentage Breakdown of Global Implantable Pulse
Generator (IPG) Market by Region for the Years 2008 and 2012
Table 13: Global Deep Brain Stimulators (DBS) Market by Region
for the Period 2007-2012 (Sales in US$ Million)
Table 14: Percentage Breakdown of Global Deep Brain
Stimulators (DBS) Market by Region for the Years 2008 and 2012
Table 15: Global Sacral Nerve Stimulators (SNS) Market by
Region for the Period 2007-2012 (Sales in US$ Million)
Table 16: Percentage Breakdown of Global Sacral Nerve
Stimulators (SNS) Market by Region for the Years 2008 and 2012
Table 17: Global Vagus Nerve Stimulators (VNS) Market by
Region for the Period 2007-2012 (Sales in US$ Million)
Table 18: Percentage Breakdown of Global Vagus Nerve
Stimulators (VNS) Market by Region for the Years 2008 and 2012
Table 19: Percentage Breakdown of Leading Players in the US
Neurostimulation Market - 2008
Table 20: Neurostimulation Market by Segment in the US:
2007-2012 (Sales in Units)
Table 21: Percentage Breakdown (Unit Sales) of
Neurostimulation Market by Segment in the US for the Years
2008 and 2012
Table 22: Neurostimulation Market by Segment in the US:
2007-2012 (Sales in US$ Million)
Table 23: Percentage Breakdown (Value Sales) of
Neurostimulation Market by Segment in the US for the Years
2008 and 2012
Table 24: Spinal Cord Stimulators Market by Segment in the US:
2007-2012 (Sales in Units)
Table 25: Percentage Breakdown (Unit Sales) of Spinal Cord
Stimulators Market by Segment in the US for the Years 2008 and
2012
Table 26: Spinal Cord Stimulators Market by Segment in the
US: 2007-2012 (Sales in US$ Million)
Table 27: Percentage Breakdown (Value Sales) of Spinal Cord
Stimulators Market by Segment in the US for the Years 2008 and
2012
Table 28: Neurostimulation Market by Segment in the Rest of
World: 2007-2012 (Sales in US$ Million)
Table 29: Percentage Breakdown of Neurostimulation Market by
Segment in the Rest of World for the Years 2008 and 2012
Table 30: Spinal Cord Stimulators Market by Segment in the
Rest of World: 2007-2012 (Sales in US$ Million)
Table 31: Percentage Breakdown of Spinal Cord Stimulators
Market by Segment in the Rest of World for the Years 2008 and
2012
COMPANIES PROFILED
